What You Should Know:
– Midi Health, a virtual clinic for women experiencing perimenopause and menopause, has secured $60M in Series B funding led by Emerson Collective, bringing Midi Health’s total funding to $100M.
– The investment highlights a growing national focus on women’s health, particularly during midlife transitions. With over 1.2 billion women globally entering perimenopause or menopause by 2030, and 85% experiencing symptoms that can significantly impact their lives, the need for specialized care is undeniable. However, only 20% of OB/GYNs and even fewer primary care physicians receive dedicated menopause training.
Addressing a Massive Gap in Women’s Healthcare
Founded in 2021, Midi Health is a pioneer in addressing this critical need. By offering virtual care focused on perimenopause and menopause, they have become the fastest-growing clinic in this space. In just one year, they’ve served tens of thousands of patients nationwide, partnered with major healthcare systems and benefits platforms, and are even offered as a workplace benefit by Fortune 100 companies.
Investment Fuels Growth and Impact
This new funding round positions Midi Health for exponential growth. The company plans to:
- Expand Insurance Coverage: Building upon their existing national reach, Midi Health will increase insurance coverage options for patients.
- Scale Clinical Expertise: By hiring and upskilling 150 additional clinicians by year-end, Midi Health will ensure efficient and personalized care for a wider patient base.
- Diversify Services: Midi Health will expand its service offerings to address a broader range of midlife women’s health concerns.
- Fuel Public Awareness: Midi Health will amplify the conversation surrounding midlife women’s health, ensuring women are empowered to seek the care they deserve.
- Reach 1 Million Women Annually: By 2029, Midi Health aims to serve over 1 million women per year, significantly impacting their well-being.
Proven Results and Economic Potential
Midi Health’s commitment to quality care is reflected in a recent survey of 2,200 patients. Over 90% of patients reported improvements in key symptoms within a few months of starting with Midi Health. These improvements ranged from hot flashes and sleep disturbances to mood and cognitive issues.
The investment in Midi Health reflects a growing national recognition of the gap in women’s healthcare, particularly around menopause. With support for innovative solutions like Midi Health on the rise, including a recent Executive Order by President Biden promoting women’s health research, Midi Health is poised to revolutionize midlife well-being for millions of women. The economic impact is also significant. A McKinsey Report suggests that addressing the menopause care gap could boost the global economy by $1 trillion by 2040.
“We started Midi with just one specific focus: helping women access world-class, expert perimenopause and menopause care, covered by insurance, and we have been at the forefront of delivering on that promise,” said Joanna Strober, CEO and Co-founder of Midi Health. “But what we have also learned is that addressing the health concerns of women in midlife is more complex than simply treating hot flashes and prescribing hormone replacement therapy. Midi takes a multi-symptom, holistic approach to care designed to help women live their best, most productive and fulfilling lives—whether that involves medication, lifestyle coaching, natural supplements, or other support. Our goal now is to expand services and scope to continue this comprehensive, personalized care far beyond menopause.”